KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $7,550,000 | +4.0% | 731,558 | +6.0% | 0.14% | -8.4% |
Q1 2021 | $7,263,000 | -6.6% | 690,410 | +37.4% | 0.15% | -12.0% |
Q4 2020 | $7,779,000 | +99.1% | 502,542 | +87.7% | 0.18% | +31.6% |
Q3 2020 | $3,908,000 | -52.9% | 267,697 | -38.9% | 0.13% | -55.7% |
Q2 2020 | $8,297,000 | – | 438,081 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,491,812 | $122,955,000 | 7.37% |
Fairmount Funds Management LLC | 652,351 | $12,356,000 | 5.51% |
Palo Alto Investors LP | 4,219,452 | $79,916,000 | 4.80% |
Avoro Capital Advisors LLC | 7,000,000 | $132,580,000 | 2.62% |
Birchview Capital, LP | 168,000 | $3,182,000 | 1.92% |
EMERALD ADVISERS, LLC | 1,244,211 | $23,565,000 | 1.03% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,036,947 | $19,640,000 | 0.93% |
Hood River Capital Management LLC | 1,007,367 | $19,080,000 | 0.86% |
Atlas Private Wealth Advisors | 48,640 | $921,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 392,831 | $7,440,000 | 0.70% |